2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Revenue | $11M | $49M | $57M | $55M |
Cost of Revenue | $905K | $3.9B | $8.8M | $0 |
Gross Profit | $10M | -$3.8B | $49M | $55M |
Gross Profit % | 92% | -7.9K% | 85% | 100% |
R&D Expenses | $0.86 | $0.63 | $0 | $0 |
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Net Income | $9.5M | $32M | $39M | $37B |
Dep. & Amort. | $0 | $563M | $0 | $0 |
Def. Tax | $0 | $0 | $0 | $0 |
Stock Comp. | $39K | $436K | $1.5M | $3.1B |
Chg. in WC | -$1.7M | -$10M | -$643K | -$6.8M |
2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|
Cash | $80M | $5.7M | $7.9M | $26B |
ST Investments | $0 | $339M | $0 | $0 |
Cash & ST Inv. | $80M | $345M | $7.9M | $26B |
Receivables | $204K | $2.2M | $1.1M | $1.9B |
Inventory | $0 | $6.9M | $0 | $0 |
Chicago Atlantic reported strong Q4 performance, deploying $90.7 million in gross originations across nine investments and maintaining a diversified portfolio of 30 companies.
The company paid $2.06 per share in dividends for 2024, with a payout ratio of approximately 99% of basic distributable earnings, and expects to maintain a dividend payout ratio of 90%-100% for 2025.
As of December 31, 2024, the loan portfolio totaled $410 million with a weighted average yield to maturity of 17.2%, and approximately 68% of the portfolio was insulated from declining interest rates.
Chicago Atlantic has $67 million in liquidity and a $490 million cannabis pipeline, aiming to remain fully deployed while maintaining a sufficient liquidity buffer in 2025.
The company continues to focus on credit quality, with only one loan on non-accrual status, and remains cautious about federal cannabis reform, underwriting loans assuming no significant regulatory changes.